Pulmonary embolism, coagulation

Version vom 11. Juni 2020, 10:21 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Since there are many organ manifestations of Hypercoagulation, subcategorization and tranccategorization was applied.

• Venous thrombosis
• Pulmonary embolism
• Cerebral embolism
• Myocardial infarction
• Arterial embolism
• Microembolism
• Hypercoagulation
• Antiphospholipid antibodies
• Disseminated intravascular coagulation
• Bleeding
• Labwork of Thrombembolism
• Prophylaxis of Thrombembolism

The unifying concept behind is Dysendoheliosis with the components Coagulation /Microthrombi, proliferative or cytopathic obstructive Endotheliosis and mediator production as well as failure of the mitigating systems and secondary vasculitis.

• thrombotic late reactions

32360432 ä. Acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia

32281926 2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients

32334995 2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia

32338707 ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient

32347323 ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

32212240 2020. Disseminated intravascular coagulation in patients with 2019?nCoV pneumonia

32338320 ä. Covid-19 treatment update: follow the scientific evidence

32306290 ä. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report

32360371 ä. Thromboembolic events in patients with SARS-CoV-2
32360679 ä. Acute limb ischemia in patients with COVID-19 pneumonia

32360372 ä. An increased severity of peripheral arterial disease in the covid-19 era
32361070 2020. Cardiovascular examination should also include peripheral arterial evaluation for COVID-19 patients

32268022 ä. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

32351657 ä. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia
32353746 2020. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

C7146714 ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

32374029 2020. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis
32369614 2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia

32353183 2020. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19

32333581 2020. Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience
32333579 2020. (clin-hemorheol-microcirc) COVID-19

32379935 2020. Response to "Lupus anticoagulant is frequent in patients with Covid-19"
32379918 2020. Coagulopathy of COVID-19 and antiphospholipid antibodies

32324958 2020. Lupus anticoagulant is frequent in patients with Covid-19

32302456 2020. Potential of heparin and nafamostat combination therapy for COVID-19

32359410 ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
32369280 ä. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

32367749 2020. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia

32324101 2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands

32324099 2020. Pulmonary, Cerebral, and Renal Thromboembolic Disease Associated with COVID-19 Infection
32374544 2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives
32378030 ä. COVID-19-Related Stroke

32133825 2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19
32133824 2020. COVID-19 complicated with DIC: 2 cases report and literatures review
32283877 2020. Prognostic value of myocardial injury in patients with COVID-19
32344469 2020. DIC in COVID-19: Implications for Prognosis and Treatment?

C7196387 ä. Extensive aortic thrombosis in a patient with Covid-19

32414639 ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?

32402423 2020. Ten key points that vascular doctors learned very quickly about COVID-19
32417015 ä. Risk of peripheral arterial thrombosis in COVID-19
32423583 2020. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19

C7177114 2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
32376101 2020. Association Between Hypoxemia and Mortality in Patients With COVID-19

32407937 2020. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China

32381264 2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
32388068 2020. Thrombotic complications in critically ill patients with COVID 19
32291094 2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19